Phase I/II study everolimus in combination with paclitaxel-carboplatin in patients with advanced adenocarcinoma of the stomach

被引：0
|
作者：
Loong, H. H. [1 ]
Mo, F. [1 ]
Li, L. [2 ]
Lee, C. [3 ]
Lam, K-C. [2 ]
Koh, J. [1 ]
Chiu, P. [4 ]
Teoh, A. [4 ]
Chan, A. T. C. [1 ]
Ng, E. [4 ]
Yeo, W. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[3] United Christian Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
402P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
    Devalingam Mahalingam
    Christos Fountzilas
    Jennifer Moseley
    Nicole Noronha
    Hue Tran
    Romit Chakrabarty
    Giovanni Selvaggi
    Matthew Coffey
    Brad Thompson
    John Sarantopoulos
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 697 - 703
  • [12] A phase II study of REOLYSINA® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
    Mahalingam, Devalingam
    Fountzilas, Christos
    Moseley, Jennifer
    Noronha, Nicole
    Tran, Hue
    Chakrabarty, Romit
    Selvaggi, Giovanni
    Coffey, Matthew
    Thompson, Brad
    Sarantopoulos, John
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 697 - 703
  • [13] Phase II study of combination paclitaxel and carboplatin in patients with advanced or recurrent endometrial cancer.
    Shan, B.
    Wang, H.
    Ren, Y.
    Tu, X.
    Jiang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [14] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [15] Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors
    Matsumoto, Koji
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 586 - 593
  • [16] Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy
    Keith T. Flaherty
    James P. Stevenson
    Stephen M. Hahn
    Maryann Redlinger
    Peter J. O'Dwyer
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 217 - 222
  • [17] Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy
    Flaherty, KT
    Stevenson, JP
    Hahn, SM
    Redlinger, M
    O'Dwyer, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (03) : 217 - 222
  • [18] Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer
    Huinink, WWT
    vanWarmerdam, LJC
    Helmerhorst, TJ
    Schaefers, MCW
    Beijnen, JH
    Rodenhuis, S
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 351 - 354
  • [19] Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
    Pivot, X
    Cals, L
    Cupissol, D
    Guardiola, E
    Tchiknavorian, X
    Guerrier, P
    Merad, L
    Wendling, JL
    Barnouin, L
    Savary, J
    Thyss, A
    Schneider, M
    ONCOLOGY, 2001, 60 (01) : 66 - 71
  • [20] Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer
    Gadgeel, SM
    Shields, AF
    Heilbrun, LK
    Labadidi, S
    Zalupski, M
    Chaplen, R
    Philip, PA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 37 - 41
12345